Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 4,925,377 7.412% | 1,148,853 (+30.42%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 5,286,174 8.000% | 1,988,694 (+60.31%) | Filing History |
| 2023-02-03 2:15 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | STATE STREET CORP STT | 3,570,127 5.370% | 3,570,127 (New Position) | Filing History |
| 2023-02-02 4:15 pm Purchase | 2022-09-01 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 5,956,558 9.000% | 1,961,558 (+49.10%) | Filing History |
| 2023-01-11 11:50 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,188,366 6.450% | 1,924,216 (+58.95%) | Filing History |
| 2022-12-30 4:30 pm Purchase | 2022-12-20 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 5,454,533 8.210% | 5,454,533 (New Position) | Filing History |
| 2022-12-27 4:15 pm Purchase | 2022-12-14 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,762,115 5.070% | 750,000 (+37.27%) | Filing History |
| 2022-08-18 3:38 pm Purchase | 2022-08-05 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 3,264,150 6.560% | 3,264,150 (New Position) | Filing History |
| 2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,079,526 10.200% | -2,652,320 (-34.30%) | Filing History |
| 2022-02-14 3:06 pm Sale | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,012,115 4.290% | -452,432 (-18.36%) | Filing History |
| 2022-02-14 3:03 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,759,505 5.900% | 655,555 (+31.16%) | Filing History |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 7,731,846 16.400% | 1,916,636 (+32.96%) | Filing History |
| 2022-02-14 1:12 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | FEDERATED HERMES INC. FHI | 2,474,500 5.280% | 2,474,500 (New Position) | Filing History |
| 2022-02-10 4:21 pm Unchanged | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 3,776,524 8.052% | 352,389 (+10.29%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 3,297,480 7.000% | 1,268,223 (+62.50%) | Filing History |
| 2021-09-10 1:36 pm Purchase | 2021-08-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,815,210 12.700% | 5,815,210 (New Position) | Filing History |
| 2021-02-16 3:10 pm Sale | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,464,547 6.570% | -49,998 (-1.99%) | Filing History |
| 2021-02-16 12:10 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,103,950 5.600% | 2,103,950 (New Position) | Filing History |
| 2021-02-12 4:43 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 6.200% | 2,319,396 (New Position) | Filing History |